Skip to content

Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study

Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03218332
Enrollment
150
Registered
2017-07-14
Start date
2011-07-04
Completion date
2030-12-30
Last updated
2021-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Traumatic Encephalopathy

Brief summary

to examine the relationship between repeated concussions and late decline of brain function. In addition, all participants agreeing to participate in the study will be asked to will their brains to The Krembil Neuroscience Centre Concussion Project at the Toronto Western Hospital with the consent and full knowledge of their families and doctors. However, it is possible to participate in the research without agreeing to a brain donation. The Project Team is specifically attempting a clinical-MRI-brain tissue research analysis to determine the exact mechanism of the damage to brain tissue following repeated concussions. This condition is known as chronic traumatic encephalopathy (CTE), and shows an abnormal protein in the brain called tau-protein.

Detailed description

We hypothesize that repeated concussions in retired professional athletes will be associated with abnormalities in neurological, neuropsychological, biofluids and neuroimaging assessments. The primary objectives of the study are: 1. To determine the effects of repeated concussions on neurological, neuropsychological and psychosocial functioning. 2. To determine the relationship between repeated concussions and neuroanatomical abnormalities in brain gray and white matter subserving cognitive and motor functions using structural MRI assessment. 3. To determine the relationship between repeated concussions and changes in the cerebrospinal fluid composition. 4. To (i) establish the infrastructure to conduct ongoing pathological examination of donated brains. 5. In order to investigate whether the effects of repeated concussions on brain function and brain structure are progressive and related to the condition known as Chronic Traumatic Encephalopathy, prospective, longitudinal, follow-up data will be collected

Interventions

DIAGNOSTIC_TESTBiomarkers for detecting possible CTE invivo

Detection biomarkers for possible CTE: Imaging/blood/CSF/PET-tau/MRI/europsychological assessment

Sponsors

The Weston A. Price Foundation
CollaboratorOTHER
University Health Network, Toronto
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
25 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

fluent in English, and a history of multiple concussions , low exposures , or no concussions (Control group ). Determination of concussion exposure will be determined as follows: Previous concussion will be based on the player's recall of injury and defined as an injury resulting from a blow to the head that caused an alteration in mental status and one or more of the following symptoms: headache, nausea, vomiting, dizziness/balance problems, fatigue, trouble sleeping, drowsiness, sensitivity to light or noise, blurred vision, difficulty remembering, and difficulty concentrating.

Exclusion criteria

Neurological disorders prior to concussions (e.g.: seizure disorder); systemic illnesses known to affect the brain (e.g., diabetes and lupus); a history of psychotic disorder; known developmental disorders (e.g., attention deficit disorder, dyslexia); history of migraines; and, active engagement in litigation.

Design outcomes

Primary

MeasureTime frameDescription
Biomarkers for possible CTEseveral visits every two years up to 10 yearsNeuropsychological/MRI/genetics/CSF/PET-tau/oculomotor

Countries

Canada

Contacts

Primary ContactMozhgan Khodadadi, MA
Mozhgan.Khodadadi@uhn.ca416-603-5800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026